Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
01 Mars 2023 - 1:36PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS
UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-39802
Clarus Therapeutics Holdings, Inc.
(Exact name of registrant as specified in its
charter)
355 S. Grand Avenue
Suite 1450
Los Angeles, CA 90071
(847) 562-4300
(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive offices)
Common Stock, $0.0001 par value per share
(Title of each class of securities covered by this
Form)
None
(Titles of all other classes of securities for
which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in
the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1) |
☒ |
|
Rule 12g-4(a)(2) |
☐ |
|
Rule 12h-3(b)(1)(i) |
☒ |
|
Rule 12h-3(b)(1)(ii) |
☐ |
|
Rule 15d-6 |
☐ |
|
Rule 15d-22(b) |
☐ |
Approximate number of holders of record as
of the certification or notice date: 0
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, Clarus Therapeutics Holdings, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly
authorized person.
Date: March 1, 2023
|
CLARUS THERAPEUTICS HOLDINGS, INC. |
|
|
|
/s/ Lawrence R. Perkins |
|
Name: |
Lawrence R. Perkins |
|
Title: |
Chief Restructuring Officer |
Blue Water Acquisition (NASDAQ:BLUW)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Blue Water Acquisition (NASDAQ:BLUW)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024
Real-Time news about Blue Water Acquisition Corporation (NASDAQ): 0 recent articles
Plus d'articles sur Clarus Therapeutics Holdings, Inc.